Founder Securities(601901)
Search documents
股市必读:方正证券(601901)11月18日主力资金净流出8375.79万元,占总成交额14.31%
Sou Hu Cai Jing· 2025-11-18 16:51
方正证券近日收到中国证券监督管理委员会批复,同意公司向专业投资者公开发行面值总额不超过300 亿元的公司债券。注册有效期为24个月,公司可在有效期内分期发行。公司将按法律法规及批复要求办 理相关事宜,并及时履行信息披露义务。 以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成 投资建议。 来自交易信息汇总:11月18日主力资金净流出8375.79万元,占总成交额14.31%。 来自公司公告汇总:方正证券获证监会批复,可向专业投资者公开发行不超过300亿元公司债券。 当日关注点 交易信息汇总资金流向 11月18日主力资金净流出8375.79万元,占总成交额14.31%;游资资金净流入5215.44万元,占总成交额 8.91%;散户资金净流入3160.36万元,占总成交额5.4%。 公司公告汇总关于获准向专业投资者公开发行公司债券的公告 截至2025年11月18日收盘,方正证券(601901)报收于8.07元,下跌0.98%,换手率0.88%,成交量72.1万 手,成交额5.85亿元。 ...
方正证券一营业部,遭监管警示
Shen Zhen Shang Bao· 2025-11-18 01:55
据广东证监局网站11月17日消息,广东证监局公布《关于对方正证券(601901)股份有限公司广州锦御 二街证券营业部采取出具警示函措施的决定》。 经查,方正证券广州锦御二街证券营业部存在以下五大问题:向投资者发送知识测评问卷的答案、基金 销售业务管理不到位、投顾业务展业不规范、人员管理不到位、合规管理机制不健全。 广东证监局表示,上述情形违反了《证券期货投资者适当性管理办法》(证监会令第130号)第三条、 第二十九条第二款,《证券投资基金销售管理办法》(证监会令第91号)第五十七条第二款,《证券投 资顾问业务暂行规定》(证监会公告〔2010〕27号)第十四条第一款、第十五条,《证券投资顾问业务 暂行规定》(证监会公告〔2020〕66号)第九条、第二十一条,《证券公司和证券投资基金管理公司合 规管理办法》(证监会令第166号)第三条、第四条的规定。 根据《证券公司和证券投资基金管理公司合规管理办法》第三十二条第一款的规定,广东证监局决定对 方正证券广州锦御二街证券营业部采取出具警示函的行政监管措施。 同日,广东证监局还公布《关于对聂晶采取出具警示函措施的决定》和《关于对雷刚采取认定为不适当 人选监管措施的决定》 ...
股市必读:方正证券(601901)11月17日主力资金净流出2343.26万元,占总成交额3.8%
Sou Hu Cai Jing· 2025-11-17 17:28
Group 1 - The core point of the news is that Fangzheng Securities has received approval from the China Securities Regulatory Commission to publicly issue corporate bonds totaling up to 30 billion yuan to professional investors [3][4] - As of November 17, 2025, Fangzheng Securities closed at 8.15 yuan, down 1.33%, with a turnover rate of 0.92% and a trading volume of 753,700 shares, resulting in a transaction amount of 616 million yuan [1] - On November 17, the net outflow of main funds was 23.43 million yuan, accounting for 3.8% of the total transaction amount, while the net inflow of speculative funds was 27.49 million yuan, making up 4.46% of the total transaction amount [2][4] Group 2 - The company has a bond issuance registration validity period of 24 months, allowing it to issue bonds in tranches within this timeframe [3] - Retail investors experienced a net outflow of 406.06 million yuan, which is 0.66% of the total transaction amount on the same day [2][4]
方正证券频陷合规困局,广州一营业部因五大问题遭监管警示
Sou Hu Cai Jing· 2025-11-17 16:38
据广东证监局网站11月17日消息,广东证监局公布《关于对方正证券股份有限公司广州锦御二街证券营 业部采取出具警示函措施的决定》。 经查,方正证券广州锦御二街证券营业部存在以下五大问题:向投资者发送知识测评问卷的答案、基金 销售业务管理不到位、投顾业务展业不规范、人员管理不到位、合规管理机制不健全。 广东证监局表示,上述情形违反了《证券期货投资者适当性管理办法》(证监会令第130号)第三条、 第二十九条第二款,《证券投资基金销售管理办法》(证监会令第91号)第五十七条第二款,《证券投 资顾问业务暂行规定》(证监会公告〔2010〕27号)第十四条第一款、第十五条,《证券投资顾问业务 暂行规定》(证监会公告〔2020〕66号)第九条、第二十一条,《证券公司和证券投资基金管理公司合 规管理办法》(证监会令第166号)第三条、第四条的规定。 根据《证券公司和证券投资基金管理公司合规管理办法》第三十二条第一款的规定,广东证监局决定对 方正证券广州锦御二街证券营业部采取出具警示函的行政监管措施。 同日,广东证监局还公布《关于对聂晶采取出具警示函措施的决定》和《关于对雷刚采取认定为不适当 人选监管措施的决定》。 今年3月28 ...
生益电子拟定增募资不超过26亿元;宁德时代:本次询价转让价格为376.12元/股丨公告精选
2 1 Shi Ji Jing Ji Bao Dao· 2025-11-17 14:42
Group 1: Financing and Investment Plans - Shengyi Electronics plans to raise no more than 2.6 billion yuan through a private placement to invest in AI computing HDI production base, smart manufacturing high-layer circuit board projects, and to supplement working capital and repay bank loans [2] - Lianmicro intends to invest 2.262 billion yuan to construct a project with an annual production capacity of 1.8 million pieces of 12-inch heavily doped substrate wafers [3] - Daimei Co. plans to invest 100 million yuan to establish a wholly-owned subsidiary focused on robotics technology [5] Group 2: Stock Performance and Trading - Furi Shares experienced a significant stock price fluctuation, with an 8-day cumulative deviation of 113.94%, indicating potential irrational speculation [2] - Tianfu Communication has set the initial inquiry transfer price at 140 yuan per share, reflecting a 7.2% discount from the closing price [7] - Ningde Times' third-largest shareholder is transferring shares at a price of 376.12 yuan per share, with full subscription from 16 institutional investors [6] Group 3: Operational Updates - Yongtai Technology's wholly-owned subsidiary is set to begin trial production of a lithium battery additive project with an annual capacity of 5,000 tons, increasing the total capacity to 10,000 tons per year [3] - Trina Solar's subsidiary signed contracts for the sale of 2.66 GWh of energy storage products, which is expected to positively impact future operating performance [5] - Yinglian Co. signed a strategic procurement contract for over 50 million square meters of composite aluminum foil materials for quasi-solid-state batteries, which will enhance its operational development in 2026-2027 [5] Group 4: Corporate Restructuring and Management - Huaxia Happiness has been designated a temporary manager for pre-restructuring by the court, pending a decision on its restructuring application [8] - The National Integrated Circuit Fund has reduced its stake in Shengke Communication by 2.49%, completing its planned share reduction [4]
因投顾业务展业不规范等问题 方正证券旗下一营业部被监管警示
Bei Jing Shang Bao· 2025-11-17 12:41
北京商报讯(记者刘宇阳)11月17日,广东证监局发布公告表示,经查,方正证券广州锦御二街证券营 业部(以下简称"广州锦御二街证券营业部")存在向投资者发送知识测评问卷的答案、基金销售业务管 理不到位、投顾业务展业不规范、人员管理不到位、合规管理机制不健全的问题。广东证监局表示,上 述情形违反了相关规定,决定对广州锦御二街证券营业部采取出具警示函的行政监管措施。 (文章来源:北京商报) ...
因投顾业务展业不规范等问题,方正证券旗下一营业部被监管警示
Bei Jing Shang Bao· 2025-11-17 12:14
北京商报讯(记者 刘宇阳)11月17日,广东证监局发布公告表示,经查,方正证券广州锦御二街证券 营业部(以下简称"广州锦御二街证券营业部")存在向投资者发送知识测评问卷的答案、基金销售业务 管理不到位、投顾业务展业不规范、人员管理不到位、合规管理机制不健全的问题。广东证监局表示, 上述情形违反了相关规定,决定对广州锦御二街证券营业部采取出具警示函的行政监管措施。 ...
方正证券:关于获准向专业投资者公开发行公司债券的公告
Zheng Quan Ri Bao· 2025-11-17 11:09
证券日报网讯 11月17日晚间,方正证券发布公告称,公司近日收到中国证券监督管理委员会《关于同 意方正证券股份有限公司向专业投资者公开发行公司债券注册的批复》(证监许可〔2025〕2416号)。 该批复同意公司向专业投资者公开发行面值总额不超过300亿元公司债券,有效期为自同意注册之日起 24个月,公司在注册有效期内可以分期发行。 (文章来源:证券日报) ...
方正证券广州锦御二街证券营业部收警示函 监管措施文号〔2025〕108号
Xin Lang Cai Jing· 2025-11-17 10:58
Core Viewpoint - Regulatory authorities have issued an administrative warning to the Guangzhou Jinyu Second Street Securities Business Department of Founder Securities Co., Ltd. due to compliance issues [1][2]. Regulatory Measures Overview - The core content of the regulatory measure is the issuance of a "warning letter," a common administrative regulatory tool in the securities industry, typically addressing compliance issues or risk hazards during operations [2]. - Specific details regarding the violations and their severity have not yet been disclosed by the regulatory authorities, and Founder Securities has not released any supplementary announcements regarding the matter [2]. Industry Impact Observation - Securities business departments serve as the service terminals for brokerages, and their compliance operations are directly related to the protection of investor rights and the stability of market order [3]. - Regulatory bodies have been increasingly strengthening compliance inspections of brokerage branches, focusing on areas such as client suitability management, information system security, and anti-money laundering obligations [3]. - The issuance of the warning letter may indicate weaknesses in one of these areas at the business department in question [3]. Company Follow-up Response - In accordance with regulatory requirements, the Guangzhou Jinyu Second Street Securities Business Department of Founder Securities must complete rectification of the issues within a specified timeframe and submit a written rectification report to the regulatory authorities [4]. - Market participants note that the compliance management level of brokerage branches will directly impact the overall business operations and brand reputation of the company, necessitating that Founder Securities quickly identify the root causes of the issues and improve its internal risk control system [4].
11月17日晚间重要公告一览
Xi Niu Cai Jing· 2025-11-17 10:20
Group 1 - Yongtai Technology's wholly-owned subsidiary has received approval for trial production of a lithium battery additive project with an annual capacity of 5,000 tons, set to begin trial production [1] - Mengke Pharmaceutical has decided to terminate its plan to issue shares to a specific entity due to ongoing disagreements among major shareholders, which could impact the company's stable operations [1] - Anhui Construction's subsidiary has been approved to register and issue debt financing tools totaling 15 billion yuan, including 5 billion yuan in short-term financing notes and 10 billion yuan in medium-term notes [2] Group 2 - Koli'er plans to repurchase shares worth between 10 million and 20 million yuan, with a maximum repurchase price of 20.94 yuan per share, to implement an employee stock ownership plan [2] - Xinhua Pharmaceutical has received approval for the production of fumaric acid volnoral raw materials, which are used to treat gastroesophageal reflux disease [3] - Lianhuan Pharmaceutical has received approval for additional specifications of tadalafil tablets, expanding its product offerings for treating erectile dysfunction and benign prostatic hyperplasia [5] Group 3 - Greenland Holdings reported an increase of 1,834 lawsuits with a total amount of 6.587 billion yuan from October 21 to November 13, 2025 [7] - Lianke Technology plans to invest up to 600 million yuan of idle funds in low-risk financial products [8] - Yinglian Co. signed a strategic procurement contract for 5,000 million square meters of composite aluminum foil with a leading new energy technology company [10] Group 4 - China Eastern Airlines reported a 10.58% year-on-year increase in passenger turnover for October, with a capacity increase of 6.84% [12] - China National Airlines reported an 8.7% year-on-year increase in passenger turnover for October, with domestic and international capacity also showing growth [15] - Oupai Home plans to use 320 million yuan of idle funds to purchase structured deposits with expected annual yields between 0.65% and 2.50% [16] Group 5 - Tianwei Food has submitted H-share issuance application materials to the Hong Kong Stock Exchange, which have been accepted by the China Securities Regulatory Commission [18] - Guizhou Aviation plans to establish a subsidiary focused on the research, production, and market expansion of intelligent automotive components, with initial operating funds of 40 million yuan [20] - Daimai Co. plans to invest 100 million yuan to establish a wholly-owned subsidiary in Shanghai focused on robotics technology [22] Group 6 - Founder Securities has received approval to issue company bonds totaling up to 30 billion yuan [24] - Hengrui Medicine has received clinical trial approvals for multiple drugs, indicating ongoing research and development efforts [26] - Zhaojing Pharmaceutical's product ZG006 has received orphan drug designation from the FDA, providing various benefits for its development in the U.S. market [39]